Skip To Main Content
Jiani C. Yin on Muck Rack

Jiani C. Yin

As seen in: Nature, Frontiers, Diagnostic Pathology, Dialnet - Universidad de La Rioja, The Journal of Biological Chemistry, Lung Cancer
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Jiani C.

Contact Jiani C., search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Comparative analysis of genomic profiles and clinical outcomes in cholangiocarcinoma and gallbladder cancer

|
By Weiqun Lu, Rujiao Liu, Cuicui Liu, Jiaohui Pang, Jiani C. Yin, Zhe Zhang
| Nature Verified
Abstract Cholangiocarcinoma (CCA) and gallbladder cancer (GBC) exhibit distinct biological behaviors and treatment responses, potentially driven by differences in their genomic landscapes. However, genomic investigations of biliary tract carcinoma (BTC) remain limited.
Open in Who Shared Issue with article?

Enhanced diagnosis of ischemic coronary artery stenosis using CT-derived fractional flow reserve based on computational fluid dynamics

|
By Jiani C. Yin, Jing Liang, Wenping Chen, Qiucang Xue
| Dialnet - Universidad de La Rioja
Ayuda Buscar en la ayuda Buscar en la ayuda Enhanced diagnosis of ischemic coronary artery stenosis using CT-derived fractional flow reserve based on computational fluid dynamics Gang Yang [1] ; Qiucang Xue [2] ; Jiani Yin [2] ; Jing Liang [2] ; Wenping Chen [2] ; Bing Zhang [3] ; Dan Mu [1] [1] Department of Radiology, Nanjing Drum Tower Hospital Clinical College of Jiangsu University, Nanjing, China [2] Department of Radiology, Drum Tower Hospital, Medical School of Nanjing University,...
Open in Who Shared Issue with article?

Personalized tumor-informed circulating tumor DNA monitoring for early detection of recurrence in postoperative pancreatic cancer

|
By Jingjing Chen, Lu Zou, Xinyuan Bai, Fan Tong, Jiayao Ni, YaRu Liu, Xiang Yan Kong, Jiani C. Yin, Fanyan Meng, Juan Du, Haochen Tang, Fufeng Wang, Huizi Sha
| Frontiers
Introduction Pancreatic cancer is a highly aggressive gastrointestinal malignancy characterized by rapid invasion and poor prognosis, representing a major global public health challenge. It is projected to become the second leading cause of cancer-related mortality in the USA by 2030 (1). Only 10%–20% of patients are eligible for surgical resection (2).
Open in Who Shared View Duplicates (20) Issue with article?
See all 8 articles